Industry News
Pharmaceutical Industry News
UPDATED: Novo touts diabetes, obesity growth, but Wegovy supply woes remain top of mind
UPDATED: Novo touts diabetes, obesity growth, but Wegovy supply woes remain top of mind fkansteiner Wed, 02/02/2022 - 09:17
Organon gives staff the day off for International Women’s Day to focus on their health
Organon gives staff the day off for International Women's Day to focus on their health sharon.coey Wed, 02/02/2022 - 08:59
Gilead’s COVID-19 antiviral Veklury blew past sales estimates in late 2021 as omicron surged, vaccinations lagged
Gilead's COVID-19 antiviral Veklury blew past sales estimates in late 2021 as omicron surged, vaccinations lagged kdunleavy Wed, 02/02/2022 - 07:39
Vuity Review: I Swapped My Reading Glasses for Magical Eyedrops
Vuity, taken daily, promises clear vision for up to 10 hours. But does it work?
Tribes Reach $590 Million Opioid Settlement With Johnson & Johnson
Money from the tentative deal would go toward addiction and treatment and would be overseen by Native American tribal leaders.
How did UCB close its $1.9B deal to buy Zogenix and its key epilepsy drug? SEC filing reveals details
How did UCB close its $1.9B deal to buy Zogenix and its key epilepsy drug? SEC filing reveals details kdunleavy Tue, 02/01/2022 - 16:53
Gilead to fork over $1.25B, pay 3% royalty on blockbuster Biktarvy in GSK patent settlement
Gilead to fork over $1.25B, pay 3% royalty on blockbuster Biktarvy in GSK patent settlement esagonowsky Tue, 02/01/2022 - 16:28
Shkreli and Vyera settle for $28M in yet another Daraprim antitrust suit
Shkreli and Vyera settle for $28M in yet another Daraprim antitrust suit fkansteiner Tue, 02/01/2022 - 14:39
GlaxoSmithKline’s HIV drug Cabenuva scores FDA nod for 2-month dosing
GlaxoSmithKline's HIV drug Cabenuva scores FDA nod for 2-month dosing kdunleavy Tue, 02/01/2022 - 11:22
Novartis’ Sandoz reportedly the target of $25B buyout bid from Carlyle and Blackstone
Novartis' Sandoz reportedly the target of $25B buyout bid from Carlyle and Blackstone fkansteiner Tue, 02/01/2022 - 11:09
Novartis, Amgen settle their dueling lawsuits over migraine drug Aimovig
Novartis, Amgen settle their dueling lawsuits over migraine drug Aimovig esagonowsky Tue, 02/01/2022 - 10:36
Sherblom’s Comera inks SPAC merger to fund subcutaneous delivery programs
Sherblom's Comera inks SPAC merger to fund subcutaneous delivery programs ntaylor Tue, 02/01/2022 - 10:35
Purdue Pharma and Sackler family close to another big opioid settlement: reports
Purdue Pharma and Sackler family close to another big opioid settlement: reports kdunleavy Tue, 02/01/2022 - 09:20
Biogen’s Aduhelm support campaign backfires as CMS receives many more comments in favor of restrictive coverage: analyst
Biogen's Aduhelm support campaign backfires as CMS receives many more comments in favor of restrictive coverage: analyst fkansteiner Tue, 02/01/2022 - 09:20
Biogen’s Aduhelm call to action backfires as CMS receives many more comments in favor of restrictive coverage: analyst
Biogen's Aduhelm call to action backfires as CMS receives many more comments in favor of restrictive coverage: analyst fkansteiner Tue, 02/01/2022 - 09:20
AstraZeneca runs first kidney disease focused Farxiga TV ad, getting in the homes of 37M people with this ‘silent disease’
AstraZeneca runs first kidney disease focused Farxiga TV ad, getting in the homes of 37M people with this ‘silent disease’ badams Tue, 02/01/2022 - 08:48
Recipharm acquires Portuguese CDMO as part of biologics expansion
Recipharm acquires Portuguese CDMO as part of biologics expansion jkeenan Tue, 02/01/2022 - 08:37
West and Corning team up for injectable drug delivery project
West and Corning team up for injectable drug delivery project ntaylor Tue, 02/01/2022 - 06:46
Stevanato doubles down on pen injector technology, expanding into indications beyond diabetes
Stevanato doubles down on pen injector technology, expanding into indications beyond diabetes ntaylor Tue, 02/01/2022 - 06:42
VCs infuse $215M into Sanofi-backed wearable subcutaneous drug delivery player Enable Injections
VCs infuse $215M into Sanofi-backed wearable subcutaneous drug delivery player Enable Injections ntaylor Tue, 02/01/2022 - 06:39